New Results
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
View ORCID ProfileTimothy O’Donnell, View ORCID ProfileElizabeth L. Christie, View ORCID ProfileJacki Novik, View ORCID ProfileB. Arman Aksoy, View ORCID ProfileDavid D. L. Bowtell, View ORCID ProfileAlexandra Snyder, View ORCID ProfileJeff Hammerbacher
doi: https://doi.org/10.1101/090134
Timothy O’Donnell
1Mount Sinai School of Medicine, New York, USA
Elizabeth L. Christie
2Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia
Jacki Novik
1Mount Sinai School of Medicine, New York, USA
B. Arman Aksoy
1Mount Sinai School of Medicine, New York, USA
David D. L. Bowtell
2Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia
Alexandra Snyder
3Deptartment of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, USA
Jeff Hammerbacher
1Mount Sinai School of Medicine, New York, USA
Article usage
Posted November 28, 2016.
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
Timothy O’Donnell, Elizabeth L. Christie, Jacki Novik, B. Arman Aksoy, David D. L. Bowtell, Alexandra Snyder, Jeff Hammerbacher
bioRxiv 090134; doi: https://doi.org/10.1101/090134
Subject Area
Subject Areas
- Biochemistry (11753)
- Bioengineering (8752)
- Bioinformatics (29201)
- Biophysics (14974)
- Cancer Biology (12100)
- Cell Biology (17413)
- Clinical Trials (138)
- Developmental Biology (9422)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18309)
- Genetics (12245)
- Genomics (16804)
- Immunology (11869)
- Microbiology (28098)
- Molecular Biology (11596)
- Neuroscience (60975)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)